ClinVar Miner

Submissions for variant NM_001382430.1(AKT1):c.288-4G>T

dbSNP: rs778501455
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001478081 SCV001682338 likely benign Cowden syndrome 6 2020-09-16 criteria provided, single submitter clinical testing
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV001478081 SCV002769002 uncertain significance Cowden syndrome 6 2019-08-28 criteria provided, single submitter clinical testing A heterozygous splice site variant was identified, NM_005163.2(AKT1):c.288-4G>T in intron 4 of the AKT1 gene. This substitution may cause aberrant splicing of exon 5 in the AKT1 gene, and affect protein function; further testing via RNA studies is required to confirm if splicing is altered. However, in silico software does not predict the splice site variant to cause aberrant splicing (NetGene2, NNSPLICE, Human Splicing Finder). The nucleotide at this position has low conservation (PhyloP, UCSC). The variant is present in the gnomAD database at a frequency of 0.0004 (1 heterozygote, 0 homozygotes). It has not been previously observed in clinical cases. Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS) with LOW CLINICAL RELEVANCE.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.